Literature DB >> 11467836

Codeposition of apolipoprotein A-IV and transthyretin in senile systemic (ATTR) amyloidosis.

J Bergström1, C Murphy, M Eulitz, D T Weiss, G T Westermark, A Solomon, P Westermark.   

Abstract

Protein material was extracted from amyloid-rich sections of formalin-fixed and paraffin-embedded heart tissue from an individual with senile systemic amyloidosis, known to contain wild-type transthyretin as major amyloid fibril protein. Amino acid sequence analysis of tryptic peptides of this material revealed in addition to transthyretin sequences, also amino acid sequence corresponding to an N-terminal fragment of apolipoprotein A-IV. In immunohistochemistry, an antiserum to a synthetic apolipoprotein A-IV peptide labeled amyloid specifically. This peptide formed spontaneously amyloid-like fibrils in vitro and enhanced fibril formation from wild-type transthyretin. We conclude that several apolipoproteins, including apolipoprotein A-IV, may be important minor amyloid constituents, promoting fibril formation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11467836     DOI: 10.1006/bbrc.2001.5260

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Micropurification techniques in the analysis of amyloid proteins.

Authors:  B Kaplan; S Shtrasburg; M Pras
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

2.  Simulation of pH-dependent edge strand rearrangement in human beta-2 microglobulin.

Authors:  Sheldon Park; Jeffery G Saven
Journal:  Protein Sci       Date:  2005-12-01       Impact factor: 6.725

3.  Genetic ablation of apolipoprotein A-IV accelerates Alzheimer's disease pathogenesis in a mouse model.

Authors:  Yujie Cui; Mingwei Huang; Yingbo He; Shuyan Zhang; Yongzhang Luo
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

4.  NBD-labeled phospholipid accelerates apolipoprotein C-II amyloid fibril formation but is not incorporated into mature fibrils.

Authors:  Timothy M Ryan; Michael D W Griffin; Michael F Bailey; Peter Schuck; Geoffrey J Howlett
Journal:  Biochemistry       Date:  2011-10-13       Impact factor: 3.162

Review 5.  Current perspectives on cardiac amyloidosis.

Authors:  Jian Guan; Shikha Mishra; Rodney H Falk; Ronglih Liao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

6.  A systemic apolipoprotein A-IV-associated amyloidosis confirmed by proteome analysis.

Authors:  Taro Murakami; Akira Takasawa; Asako Moriki; Yusuke Igaki; Hiroshi Ikeda; Kazuyuki Murase; Kohichi Takada; Kazufumi Magara; Tomoyuki Aoyama; Yusuke Ono; Daisuke Kyuno; Kumi Takasawa; Masaki Murata; Makoto Osanai
Journal:  Virchows Arch       Date:  2021-03-10       Impact factor: 4.064

Review 7.  Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?

Authors:  Xinyi Li; Joel N Buxbaum
Journal:  Mol Neurodegener       Date:  2011-11-23       Impact factor: 14.195

8.  Quantitative interrogation of protein co-aggregation using multi-color fluorogenic protein aggregation sensors.

Authors:  Yulong Bai; Wang Wan; Yanan Huang; Wenhan Jin; Haochen Lyu; Qiuxuan Xia; Xuepeng Dong; Zhenming Gao; Yu Liu
Journal:  Chem Sci       Date:  2021-05-20       Impact factor: 9.825

9.  Serine protease HtrA1 accumulates in corneal transforming growth factor beta induced protein (TGFBIp) amyloid deposits.

Authors:  Henrik Karring; Ebbe Toftgaard Poulsen; Kasper Runager; Ida B Thøgersen; Gordon K Klintworth; Peter Højrup; Jan J Enghild
Journal:  Mol Vis       Date:  2013-04-12       Impact factor: 2.367

10.  Transthyretin and amyloid in the islets of Langerhans in type-2 diabetes.

Authors:  Gunilla T Westermark; Per Westermark
Journal:  Exp Diabetes Res       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.